Cargando…
Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies
Skin fibrosis still constitutes an unmet clinical need. Although pharmacological strategies are at the forefront of scientific and technological research and innovation, their clinical translation is hindered by the poor predictive capacity of the currently available in vitro fibrosis models. Indeed...
Autores principales: | Coentro, João Q., May, Ulrike, Prince, Stuart, Zwaagstra, John, Ritvos, Olli, Järvinen, Tero A.H., Zeugolis, Dimitrios I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576412/ https://www.ncbi.nlm.nih.gov/pubmed/34765594 http://dx.doi.org/10.3389/fbioe.2021.756399 |
Ejemplares similares
-
Editorial: Highlights From TERMIS EU 2019
por: Chatzinikolaidou, Maria, et al.
Publicado: (2020) -
Electrospun Polymers in Cartilage Engineering—State of Play
por: Yilmaz, Elif Nur, et al.
Publicado: (2020) -
Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited
por: Puerta Cavanzo, Nataly, et al.
Publicado: (2021) -
Editorial: Fibrous Assemblies: From Synthesis and Nanostructure Characterization to Materials Development and Application
por: Giannini, Cinzia, et al.
Publicado: (2021) -
Macromolecular crowding in animal component-free, xeno-free and foetal bovine serum media for human bone marrow mesenchymal stromal cell expansion and differentiation
por: Korntner, Stefanie H., et al.
Publicado: (2023)